PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Buddleja globosa exhibits antimicrobial and regenerative properties; when incorporated into polymeric scaffolds, it shows efficacy against dual-species biofilms of Pseudomonas aeruginosa and Staphylococcus aureus in murine models [PMID:42196221, PMID:40509314].
Methanol extracts demonstrated antinociceptive activity in tail flick, formalin, and writhing models [PMID:18639621].
Extracts (0.05-1 mg/mL) acted as potent inhibitors of platelet aggregation in response to collagen, convulsion, and ADP [PMID:29321991].
Methanolic extract and an enriched iridoid fraction (6-O-methylcatalpol) showed trypanocidal activity against T. cruzi trypomastigotes [PMID:40941913].
Stem bark lipophilic extracts showed antifungal activity against three dermatophytic fungal species [PMID:11000021].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36986757 (2023) — Anti-Inflammatory Chilean Endemic Plants. · Pharmaceutics
- 2.PMID: 28386629 (2017) — An In Vitro Study of the Antioxidant and Antihemolytic Properties of Buddleja globosa (Matico). · The Journal of membrane biology
- 3.PMID: 29321991 (2018) — Buddleja globosa (matico) prevents collagen-induced platelet activation by decreasing phospholipase C-gamma 2 and protein kinase C phosphorylation signaling. · Journal of traditional and complementary medicine
- 4.PMID: 18639621 (2008) — Antinociceptive activity of Buddleja globosa (matico) in several models of pain. · Journal of ethnopharmacology
- 5.PMID: 42196221 (2026) — Optimization of Buddleja globosa-Loaded Polymeric Scaffolds for the Treatment of Biofilm-Infected Wounds.